This study tests whether a daily pill called Xanamem can safely help people with mild or moderate Alzheimer's dementia. About 247 adults aged 50 and older will receive either Xanamem or a placebo for 36 weeks, with an option to continue treatment for up to 108 weeks. The goal is …
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated May 15, 2026 11:54 UTC